|
Market Cap (21-May) $526,472,800 (439th) |
Close (30-Jun) $4.40 |
Volume (30-Jun) 565,229 |
Shortsold (5-May) 2,410,503 (2.97%) (86th) |
|
52w High $7.31 |
52w Low $3.74 |
P/E 285.71 |
EPS -1.56 |
MYX released this announcement to the ASX on 21 June 2021, 8:26. The announcement is not marked as price sensitive, and is 3 page(s) in length and 134.12kb in size.
You can view all announcements from MYX and see how they appear on a price chart on the announcements page.
At the date of this announcement, MYX was 1.158% short sold according to ASIC data. It was ranked the 158th most shorted stock on the ASX. It is now ranked as the 86th most shorted stock on the ASX with 2.967% of total shares short sold as of the latest reported data (05 May 2025).
| Other Recent Announcements from MYX | |
|---|---|
| Notification of cessation of securities - MYX | 30 June 2023, 16:11 |
| Update - Notification of buy-back - MYX | 30 June 2023, 8:19 |
| Update - Notification of buy-back - MYX | 29 June 2023, 8:20 |
| NEXTSTELLIS oral contraceptive now available in the US | 21 June 2021, 8:26 |
| NEXTSTELLIS FDA exclusivity & phase III data published | 27 May 2021, 8:47 |
| Becoming a substantial holder | 14 May 2021, 16:09 |
| Appendix 2A and Notice under ASX Listing Rule 3.10A | 13 May 2021, 16:40 |
You must be logged in to post a reply.
Mayne Pharma Group 